TABLE 1

Effects of transfection of varying amounts of PLC-γ sense or dominant negative mutant DNA on both NF-κB activity and I-κBα levels in intestinal Caco-2 monolayers

Intestinal cells stably transfected with varying amounts of PLC-γ sense DNA (1, 2, 3, or 5 μg) were exposed to oxidant (H2O2, 0.5 mM). In separate studies, cells transfected with varying amounts of a PLC-γ dominant negative DNA, namely, PLCz (1, 2, 3, or 5 μg), were treated with EGF (10 ng/ml) before exposure to oxidant. Wild-type (WT) cells, which are not transfected, are also shown. Monolayer NF-κB (p65) activity and I-κBα levels were assessed as described under Materials and Methods.


Treatment

NF-κB Activity (OD, 450 nm)

I-κBα Levels (% Maximum)
Vehicle 0.09 ± 0.01 100 ± 2.0
H2O2 [WT] 1.55 ± 0.25* 14 ± 7.0*
H2O2 [1-μg sense PLC-γ DNA] 1.28 ± 0.08* 29 ± 0.6*
H2O2 [2-μg sense PLC-γ DNA] 0.75 ± 0.09* 47 ± 3.0*
H2O2 [3-μg sense PLC-γ DNA] 0.27 ± 0.05* 84 ± 4.0*
H2O2 [5-μg sense PLC-γ DNA] 0.28 ± 0.09* 82 ± 6.0*
EGF (10 ng/ml) + H2O2 [WT] 0.12 ± 0.02 95 ± 0.5
EGF (10 ng/ml) + H2O2 [1-μg dominant neg. PLC-γ DNA] 0.23 ± 0.06* 80 ± 1.0*
EGF (10 ng/ml) + H2O2 [2-μg dominant neg. PLC-γ DNA] 0.89 ± 0.02* 56 ± 2.0*
EGF (10 ng/ml) + H2O2 [3-μg dominant neg. PLC-γ DNA] 1.39 ± 0.25* 22 ± 5.0*
EGF (10 ng/ml) + H2O2 [5-μg dominant neg. PLC-γ DNA]
1.35 ± 0.10*
23 ± 3.0*
  • Values are means ± S.E.M. n = 4 to 6 per group.

  • * p < 0.05 compared with the vehicle.

  • p < 0.05 compared with H2O2 in WT cells.

  • p < 0.05 compared with corresponding cells transfected with 3 μg of sense PLC-γ DNA and exposed to H2O2 or cells transfected with 3 μg of PLC-γ dominant mutant DNA and treated with EGF and then H2O2.